Lionshead Wealth Management LLC Purchases Shares of 714 UnitedHealth Group Incorporated (NYSE:UNH)

Lionshead Wealth Management LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 714 shares of the healthcare conglomerate’s stock, valued at approximately $361,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Czech National Bank increased its position in shares of UnitedHealth Group by 6.1% during the fourth quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate’s stock worth $100,937,000 after acquiring an additional 11,426 shares in the last quarter. Aprio Wealth Management LLC increased its position in shares of UnitedHealth Group by 15.9% during the fourth quarter. Aprio Wealth Management LLC now owns 1,337 shares of the healthcare conglomerate’s stock worth $676,000 after acquiring an additional 183 shares in the last quarter. Matrix Trust Co boosted its holdings in UnitedHealth Group by 6.6% during the fourth quarter. Matrix Trust Co now owns 3,634 shares of the healthcare conglomerate’s stock worth $1,838,000 after purchasing an additional 225 shares during the last quarter. Winthrop Advisory Group LLC boosted its holdings in UnitedHealth Group by 2.4% during the fourth quarter. Winthrop Advisory Group LLC now owns 1,301 shares of the healthcare conglomerate’s stock worth $658,000 after purchasing an additional 31 shares during the last quarter. Finally, Fiduciary Alliance LLC boosted its holdings in UnitedHealth Group by 260.7% during the fourth quarter. Fiduciary Alliance LLC now owns 9,893 shares of the healthcare conglomerate’s stock worth $5,005,000 after purchasing an additional 7,150 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms recently weighed in on UNH. HSBC restated a “hold” rating and set a $490.00 price target on shares of UnitedHealth Group in a report on Tuesday, April 22nd. JPMorgan Chase & Co. cut their price target on shares of UnitedHealth Group from $652.00 to $525.00 and set an “overweight” rating on the stock in a report on Thursday, April 24th. Truist Financial dropped their target price on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating on the stock in a research note on Monday, April 21st. Royal Bank of Canada dropped their target price on shares of UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. Finally, Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Four equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $596.86.

Read Our Latest Research Report on UnitedHealth Group

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $380.72 on Monday. UnitedHealth Group Incorporated has a 1-year low of $378.54 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $345.37 billion, a PE ratio of 24.56, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The firm’s 50 day simple moving average is $488.01 and its 200 day simple moving average is $522.04.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter in the prior year, the company earned $6.91 earnings per share. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 2.21%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 35.18%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.